News

Results - EIC Pathfinder Open 2021 call – deadline 25 May 2021

Published on
| 5 years ago
Programmes
  • EIC

For the call European Innovation Council (EIC) Pathfinder Open 2021 (deadline 25 May 2021) in total 908 proposals were submitted, 868 evaluated and 56 proposals selected for funding, of which five with a coordinator based in Flanders:

- imec, project “QuMicro - Quantum Microwave Detection with Diamond Spins”

- Universiteit Antwerpen, project “PRINGLE - Protein-based next generation electronics”

- Universiteit Gent, project “CSOC - Chip-scale Optical Atomic Clock”

- Katholieke Universiteit Leuven, project “SynEry - Bottom-up reconstruction of a Synthetic Erythrocyte”

- Vrije Universiteit Brussel, project “VortexLC - Vortex enhanced liquid chromatography for HbA1c monitoring based diabetes management in a globalized setting”

More information on submission statistics and awarded projects can be found in this EIC news article

Related news

myOverview

Sign up for personalised information

Stay informed about Horizon Europe, Digital Europe & EDF, filtered on what matters to you.

  • News in your domains
  • Event announcements
  • A personal dashboard
Sign up now

Only for stakeholders located in Flanders

Latest news

2069 articles available Browse all news
  • ERC
  • MSCA
  • Research Infrastructures
  • EIC

Innonext the Next Generation Innovation Talent’s Initiative call open

InnoNext is a two-year project funded under the European Innovation Council (EIC) that was extended by one year until 31 July 2027. The objective of the project is to match visiting researchers with start-ups or SMEs which host the visiting researchers during an internship. The researchers and companies involved are funded by an EU funding...

Read more
  • Research Infrastructures
  • Health
  • Digital, Industry & Space
  • Climate, Energy, Mobility

Lasers4EU 6th Transnational Access programme for laser research and innovation

The Lasers4EU project consortium of research infrastructures provides access to state-of-the-art laser technologies and services from primary and secondary laser sources to a wide range of laser-based instruments and techniques at 27 leading laser research institutions across Europe. More information is available in their mission and on the...

Read more

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.